pipette
ESEspañol

Attitudes and Perceptions of Generative Artificial Intelligence Chatbots in the Peer Review of Traditional, Complementary, and Integrative Medicine Research: A Large-Scale, International Cross-Sectional Survey

J. Y. Ng, J. Tan, K. Adapa, P. K. Gupta, M. Gupta, S. Li, D. H. Mehta, M. Ring, M. Shridhar, J. P. Souza, T. Yoshino, M. S. Lee, H. Cramer

Preprint

In the authors' words

Background: Generative artificial intelligence (GenAI) chatbots are being explored for their potential to support the peer review process by improving efficiency and analytical capacity. While early applications show promise, concerns regarding ethics, privacy, and research integrity remain, and their use within traditional, complementary, and integrative medicine (TCIM) remains underexplored. This study examines TCIM researchers' attitudes and perceptions regarding the use of GenAI chatbots in peer review through a large-scale international survey. Methods: Corresponding authors of TCIM-related publications indexed in Ovid MEDLINE were invited to participate in an online, anonymous, international cross-sectional survey distributed via SurveyMonkey. The questionnaire collected data on demographic characteristics, the perceived importance of GenAI in peer review, the likelihood of adoption, and the perceived benefits and concerns. Results: A total of 889 eligible respondents participated. Overall, 40.25% (n=285/708) reported a positive perception of GenAI in peer review, and 41.67% (n=295/708) considered it important to the field. 34.24% researchers reported being likely (n=253/739) or 18.27% (135/739) very likely (totaling 52.51%) to use GenAI in peer review, highlighting a gap between perceived importance and intended adoption. Identified benefits included improved efficiency (50.72%, n=350/690), reduced reviewer workload (51.16%, n=353/690), and generation of constructive feedback (46.30%, n=319/689), reflecting respondents selecting "agree." Concerns included bias (49.85%, n=333/668), lack of transparency (42.86%, n=285/665), inaccuracies (49.40%, n=329/666), accountability challenges (45.20%, n=301/666), and data privacy risks (36.05%, n=239/663). Most respondents believed that peer reviewers require either some training (43.91%, n=310/706) or a lot of training (40.93%, n=289/706) to use GenAI chatbots effectively in peer review. Conclusion: Respondents reported perceived benefits of GenAI in peer review, alongside notable concerns regarding its use. While opinions were mixed, findings suggest both perceived utility and apprehension about potential risks. Further work is needed to understand these perspectives better and to explore how GenAI can be responsibly integrated into peer-review processes.

Main resultLimitation the authors admit

Appeared: Tuesday, November 17. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.12.26366211